Apidra (insulin glulisine)

**Product type:** Human Prescription Drug

**Active ingredient:** INSULIN GLULISINE

**Strength:** 100 [iU]/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous; Subcutaneous

**Labeler:** sanofi-aventis U.S. LLC

**Marketing category:** BLA (BLA021629)

**Pharmacologic class:** Insulin Analog [EPC], Insulin [Chemical/Ingredient]